Interestingly, CD38 expression on CD8+ T-cells is significantly increased in AD patients as compared with age-matched controls (Gate et al., 2020) and these activated T-cells are able to infiltrate into the CNS exerting toxic effects. The gene discussed is CD38; the disease is Alzheimer disease.